Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Jan 24;20(3):2123.
doi: 10.3390/ijerph20032123.

Herpes Zoster Risk in Patients with Rheumatoid Arthritis and Its Association with Medications Used

Affiliations
Observational Study

Herpes Zoster Risk in Patients with Rheumatoid Arthritis and Its Association with Medications Used

Sithembiso Tiyandza Dlamini et al. Int J Environ Res Public Health. .

Abstract

Rheumatoid arthritis (RA) was associated with the risk of incident herpes zoster (HZ), which might be influenced by medication use by RA patients. We aimed to investigate the association of RA with the risk of incident HZ and how the HZ risk effected by RA medications in CIC RA patients. We conducted an observational study including population-based representative insurance claims data of 19,673 patients with RA and 39,346 matched patients without RA during 1997-2010 from the Taiwan National Health Insurance Research Database; we identified 1651 patients with catastrophic illness-certified (CIC) RA and 11,557 matched patients with non-CIC RA. Exploratory analyses assessed the association between RA/CIC RA and risk of incident HZ and its complications. The association of prescribed medications with HZ risk in CIC RA patients was also estimated. The incidence rates of HZ were higher in CIC RA patients and non-CIC RA than in the matched people without RA (21.95 and 14.03 vs. 7.36 events per 1000 person-years, respectively). The adjusted incidence rate ratio (95% confidence interval (CI)) for HZ was 1.74 (1.65-1.84) in RA patients vs. matched non-RA and 1.65 (1.44-1.89) in CIC RA patients vs. non-CIC RA. For HZ complications, RA had a 2.85-fold higher risk than non-RA, and CIC RA had a 1.78-fold higher risk than non-CIC RA. Moreover, in CIC RA patients, prednisolone use was associated with incident HZ risk compared with prednisolone nonuse (adjusted odds ratio 1.48, 1.08-2.03); prolonged prednisolone use (approximately 5 years) increased the risk (adjusted odds ratio 2.16, 1.46-3.19). Our results suggested that RA was positively associated with HZ risk, particularly in RA patients with prednisolone use.

Keywords: herpes zoster; incidence rate ratio; observational study; prednisolone; rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

None of the authors has any conflicts of interest to declare.

Figures

Figure 1
Figure 1
Flowchart for the selection of patients. RA: rheumatoid arthritis; CIC: catastrophic illness-certified; HZ: herpes zoster; comparison group = non-RA.
Figure 2
Figure 2
Cumulative incidence rates of herpes zoster. (a) Differences in the cumulative incidence rates of herpes zoster between patients with RA and comparison group. (b) Differences in the cumulative incidence rates of herpes zoster between RA patients with and without a CIC by using the log-rank test and Kaplan–Meier analysis. RA: rheumatoid arthritis, CIC: catastrophic illness certificate.

References

    1. Dayan R.R., Peleg R. Herpes zoster—Typical and atypical presentations. Postgrad. Med. 2017;129:567–571. doi: 10.1080/00325481.2017.1335574. - DOI - PubMed
    1. Freer G., Pistello M. Varicella-zoster virus infection: Natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol. 2018;41:95–105. - PubMed
    1. Kinchington P.R., Leger A.J., Guedon J.M., Hendricks R.L. Herpes simplex virus and varicella zoster virus, the house guests who never leave. Herpesviridae. 2012;3:5. doi: 10.1186/2042-4280-3-5. - DOI - PMC - PubMed
    1. Cohen J.I. Clinical practice: Herpes zoster. N. Engl. J. Med. 2013;369:255–263. doi: 10.1056/NEJMcp1302674. - DOI - PMC - PubMed
    1. Oxman M., Levin M., Johnson G., Schmader K., Straus S., Gelb L., Arbeit R., Simberkoff M., Gershon A., Davis L., et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. N. Engl. J. Med. 2005;352:2271–2284. doi: 10.1056/NEJMoa051016. - DOI - PubMed

Publication types

MeSH terms